Mga Batayang Estadistika
| CIK | 1841389 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Revolution Healthcare Acquisition Corp - Class A
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 14, 2023 |
REVOLUTION HEALTHCARE ACQUISITION CORP / Alyeska Investment Group, L.P. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 6, 2023 |
REVOLUTION HEALTHCARE ACQUISITION CORP / Weiss Asset Management LP Passive Investment SC 13G/A 1 revh13ga31dec2022.htm CUSIP NO. 76155Y108 SCHEDULE 13G/A PAGE 1 OF 10 PAGES =============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* REVOLUTION HEALTHCARE ACQUISITION CORP. - (Name of Issuer) Class A Common Stock, $0.0 |
|
| December 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. 001-40190 Commission File Number REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant |
|
| December 6, 2022 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF REVOLUTION HEALTHCARE ACQUISITION CORP. REVOLUTION HEALTHCARE ACQUISITION CORP., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), hereby certifies as follows: 1. The name of the Corporation is Revolution Healthcare Acquisition Corp. The original Certificate |
|
| December 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 6, 2022 (December 2, 2022) REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisd |
|
| November 28, 2022 |
Revolution Healthcare Acquisition Corp. Will Redeem Public Shares EXHIBIT 99.1 Revolution Healthcare Acquisition Corp. Will Redeem Public Shares Cambridge, MA, November 28, 2022 ? Revolution Healthcare Acquisition Corp. (the ?Company?) (NASDAQ: REVH), a special purpose acquisition company, today announced that, the Company will redeem all of its outstanding shares of Class A Common Stock, par value $0.0001, issued by the Company in its initial public offering (t |
|
| November 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 28, 2022 REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisdiction of incorpor |
|
| November 28, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 28, 2022 REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisdiction of incorpor |
|
| November 10, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 7, 2022 |
DEF 14A 1 d292335ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Com |
|
| October 24, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| August 10, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00 |
|
| May 11, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| April 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2022 REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisdiction of inc |
|
| March 21, 2022 |
Exhibit 10.9 March 17, 2021 Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) to be entered into by and b |
|
| March 21, 2022 |
Description of the Registrant’s Securities.* Exhibit 4.5 DESCRIPTION OF SECURITIES The following summary of the material terms of the securities of Revolution Healthcare Acquisition Corp. (?we,? ?us,? ?our? or ?the company?) is not intended to be a complete summary of the rights and preferences of such securities and is subject to and qualified by reference to our amended and restated certificate of incorporation incorporated by reference as |
|
| March 21, 2022 |
Indemnity Agreement dated March 17, 2021* Exhibit 10.4 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of March 17, 2021, by and between Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), and the undersigned (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless th |
|
| March 21, 2022 |
Warrant Agreement between the Registrant and Continental Stock Transfer & Trust Company * Exhibit 4.4 WARRANT AGREEMENT between REVOLUTION HEALTHCARE ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS WARRANT AGREEMENT (this ?Agreement?), dated as of March 17, 2021, is by and between Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agen |
|
| March 21, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal period ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40190 Revoluti |
|
| February 14, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Revolution Healthcare Acquisition Corp. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 76155Y108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to des |
|
| February 14, 2022 |
REVOLUTION HEALTHCARE ACQUISITION CORP / Alyeska Investment Group, L.P. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2022 |
REVOLUTION HEALTHCARE ACQUISITION CORP / Sculptor Capital LP - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* REVOLUTION HEALTHCARE ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 76155Y108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropr |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Revolution Healthcare Acquisition Corp. (Name of Issuer) Class A common stock, par value $0.0001 per share (the “Shares”) (Title of Class o |
|
| January 28, 2022 |
REVOLUTION HEALTHCARE ACQUISITION CORP / Weiss Asset Management LP Passive Investment CUSIP NO. 76155Y108 SCHEDULE 13G/A PAGE 1 OF 10 PAGES =============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* REVOLUTION HEALTHCARE ACQUISITION CORP. - (Name of Issuer) Class A Common Stock, $0.0001 par value per share - (Title |
|
| January 13, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to REV |
|
| December 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 23, 2021 REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisdiction of incorpor |
|
| November 19, 2021 |
EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the common stock of Revolution Healthcare Acquisition Corp., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf |
|
| November 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 (Amendment No. )* Revolution Healthcare Acquisition Corp. (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) 76155Y108 |
|
| November 9, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to REVOLUTION HEALTHCARE |
|
| October 8, 2021 |
=============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2021 REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisdiction of incorporat |
|
| August 10, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to REVOLUTION HEALTHCARE ACQU |
|
| May 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 18, 2021 |
SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* REVOLUTION HEALTHCARE ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 76155Y108** (CUSIP Number) May 10, 2021 (Date of Event Which Requires Filing of this Statement) Check the appr |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING 1-40190 (Commission File Number) (Check one): Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q x Form 10-D ¨ Form N-SAR ¨ Form N-CSR ¨ For Period Ended: March 31, 2021 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on F |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2021 REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisdiction of incorporation |
|
| May 10, 2021 |
Exhibit 99.1 Revolution Healthcare Acquisition Corp. Announces the Separate Trading of its shares of Class A Common Stock and Warrants Commencing May 10, 2021 Boston ? May 10, 2021 ? Revolution Healthcare Acquisition Corp. (Nasdaq: REVHU) (the ?Company?) today announced that, commencing May 10, 2021, holders of the SAILSM securities sold in the Company?s initial public offering of SAILSM securitie |
|
| May 10, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2021 REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisdiction of incor |
|
| March 26, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2021 REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisdiction of inc |
|
| March 26, 2021 |
REVOLUTION HEALTHCARE ACQUISITION CORP. Exhibit 99.1 REVOLUTION HEALTHCARE ACQUISITION CORP. Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of March 22, 2021 F-3 Notes to Financial Statement F-4 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and the Board of Directors of Revolution Healthcare Acquisition Corp. Opinion on the Financial Statement We have audited the accompanying b |
|
| March 22, 2021 |
Exhibit 10.2 REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT (this ?Agreement?), dated as of March 17, 2021, is made and entered into by and among Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), REV Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), Health Assurance Economy Foundation, a Delaware nonp |
|
| March 22, 2021 |
Exhibit 10.3 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of March 17, 2021 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and between Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), REV Sponsor LLC, a Delaware limited liability |
|
| March 22, 2021 |
Exhibit 10.4 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of March 17, 2021, by and between Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), and the undersigned (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless th |
|
| March 22, 2021 |
Exhibit 3.2 BYLAWS OF REVOLUTION HEALTHCARE ACQUISITION CORP. a Delaware corporation Article I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be located at 1209 Orange Street, Wilmington, New Castle County, Delaware 19801. The name of the corporation?s registered agent at such address shall be The Corporation Trust Company. The registe |
|
| March 22, 2021 |
Administrative Services Agreement between the Company and the Sponsor Exhibit 10.5 REVOLUTION HEALTHCARE ACQUISITION CORP. 20 University Road Cambridge, MA 02138 March 17, 2021 REV Sponsor LLC 20 University Road Cambridge, MA 02138 Re: Administrative Support Agreement Ladies and Gentlemen: This letter agreement by and between Revolution Healthcare Acquisition Corp. (the ?Company?) and REV Sponsor LLC (?Sponsor?), dated as of the date hereof, will confirm our agreeme |
|
| March 22, 2021 |
Amended and Restated Certificate of Incorporation Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF REVOLUTION HEALTHCARE ACQUISITION CORP. March 16, 2021 Revolution Healthcare Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is ?Revolution Healthcare Acquisition Corp.?. The original certificate of inco |
|
| March 22, 2021 |
Warrant Agreement between Continental Stock Transfer & Trust Company and the Company Exhibit 4.1 NUMBER SAILSM securities U- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 76155Y108 REVOLUTION HEALTHCARE ACQUISITION CORP. SAILSM (STAKEHOLDER ALIGNED INITIAL LISTING) SECURITY CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE-FIFTH OF ONE WARRANT TO PURCHASE ONE SHARE OF CLASS A COMMON STOCK THIS CERTIFIES THAT is the owner of SAILSM securities. Each SAILSM security (?SAILSM securi |
|
| March 22, 2021 |
Underwriting Agreement between the Company and Morgan Stanley & Co. LLC Exhibit 1.1 50,000,000 SAILSM Securities Revolution Healthcare Acquisition Corp. UNDERWRITING AGREEMENT MORGAN STANLEY & CO. LLC March 17, 2021 1585 Broadway New York, New York 10036 As Representative of the several Underwriters listed in Schedule I to the Agreement Dear Ladies and Gentlemen: 1. Introductory. Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), agrees w |
|
| March 22, 2021 |
Private Placement Warrants Purchase Agreement between the Company and the Sponsor Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of March 17, 2021 by and between Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a limited purpose trust company (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S |
|
| March 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2021 REVOLUTION HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40190 86-1403778 (State or other jurisdiction of inc |
|
| March 18, 2021 |
TABLE OF CONTENTS ?Pursuant to Rule 424(b)(4) ?Registration No. 333-253729? PROSPECTUS $500,000,000 Revolution Healthcare Acquisition Corp. 50,000,000 SAILSM (Stakeholder Aligned Initial Listing) Securities Revolution Healthcare Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization |
|
| March 17, 2021 |
* * * [Signature Page Follows] March 17, 2021 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| March 17, 2021 |
Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 March 17, 2021 VIA EDGAR Office of Energy & Transportation Division of Corporation Finance U.S. Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Attention: Erin Martin Re: Revolution Healthcare Acquisition Corp. Acceleration Request for Registration Statement on Form S-1 File No. |
|
| March 16, 2021 |
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on March 16, 2021 No. |
|
| March 16, 2021 |
Goodwin Procter LLP 601 Marshall Street Redwood City, CA 94063 goodwinlaw.com +1 650 752 3100 March 16, 2021 Erin Martin Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Revolution Healthcare Acquisition Corp. Amendment No. 1 to Registration Statement on Form S-1 Filed March 16, 2021 CIK No. 0001841389 Dear Ms. Martin: This letter is |
|
| March 15, 2021 |
* * * [Signature Page Follows] March 15, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| March 15, 2021 |
Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 March 15, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Erin Martin Re: Revolution Healthcare Acquisition Corp. Acceleration Request for Registration Statement on Form S-1 File No. 333-253729 Dear Ms. Martin: Referen |
|
| March 12, 2021 |
* * * [Signature Page Follows] CORRESP 1 filename1.htm March 12, 2021 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Revolution Healthcare Acquisition Corp. Registration Statement on Form S-1 Filed March 1, 2021, as amended File No. 333-253729 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of |
|
| March 12, 2021 |
Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 CORRESP 1 filename1.htm Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 March 12, 2021 VIA EDGAR Office of Energy & Transportation Division of Corporation Finance U.S. Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Attention: Erin Martin Re: Revolution Healthcare Acquisition Corp. Acceleration Request for Registration Stateme |
|
| March 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Revolution Healthcare Acquisition Corp. (Exact Name of Registrant as Specified in Its Charter) Delaware 86-1403778 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) 20 |
|
| March 1, 2021 |
Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant. Exhibit 4.4 WARRANT AGREEMENT between REVOLUTION HEALTHCARE ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS WARRANT AGREEMENT (this ?Agreement?), dated as of February [?], 2021, is by and between Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant |
|
| March 1, 2021 |
Exhibit 10.4 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of February [], 2021, by and between Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), and the undersigned (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless |
|
| March 1, 2021 |
Exhibit 10.9 February [], 2021 Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) to be entered into by an |
|
| March 1, 2021 |
Form of Underwriting Agreement. Exhibit 1.1 50,000,000 SAILSM Securities Revolution Healthcare Acquisition Corp. UNDERWRITING AGREEMENT MORGAN STANLEY & CO. LLC [?], 2021 1585 Broadway New York, New York 10036 As Representative of the several Underwriters listed in Schedule I to the Agreement Dear Ladies and Gentlemen: 1. Introductory. Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), agrees with t |
|
| March 1, 2021 |
Promissory Note, dated as of January 11, 2021, between the Registrant and the Sponsor. Exhibit 10.6 THIS PROMISSORY NOTE (?NOTE?) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| March 1, 2021 |
Exhibit 10.8 Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, MA 02138 January 11, 2021 Health Assurance Economy Foundation 376 Brannan St. San Francisco, CA 94107 RE: Securities Subscription Agreement Ladies and Gentlemen: This agreement (this ?Agreement?) is entered into on January 11, 2021 by and between Health Assurance Economy Foundation, a Delaware nonprofit nonstock cor |
|
| March 1, 2021 |
Form of Private Placement Warrants Purchase Agreement between the Registrant and the Sponsor. Exhibit 10.3 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of February [], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and between Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), REV Sponsor LLC, a Delaware limited liabil |
|
| March 1, 2021 |
Form of Code of Conduct and Ethics. Exhibit 14 REVOLUTION HEALTHCARE ACQUISITION CORP. CODE OF ETHICS 1. Introduction The Board of Directors of Revolution Healthcare Acquisition Corp. has adopted this code of ethics (the ?Code?), which is applicable to all directors, officers and employees, to: ? promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and profes |
|
| March 1, 2021 |
Exhibit 4.3 Form of Warrant Certificate [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW REVOLUTION HEALTHCARE ACQUISITION CORP. Incorporated Under the Laws of the State of Delaware CUSIP 76155Y108 Warrant Certificate This Warrant Certificate certifies that , or registered assigns |
|
| March 1, 2021 |
Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of February [], 2021 by and between Revolution Helathcare Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, No |
|
| March 1, 2021 |
Form of Amended and Restated Bylaws. Exhibit 3.4 AMENDED AND RESTATED BYLAWS OF REVOLUTION HEALTHCARE ACQUISITION CORP. (THE ?CORPORATION?) ARTICLE I OFFICES Section 1.1 Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corpor |
|
| March 1, 2021 |
BYLAWS OF REVOLUTION HEALTHCARE ACQUISITION CORP. a Delaware corporation Article I Exhibit 3.3 BYLAWS OF REVOLUTION HEALTHCARE ACQUISITION CORP. a Delaware corporation Article I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be located at 1209 Orange Street, Wilmington, New Castle County, Delaware 19801. The name of the corporation?s registered agent at such address shall be The Corporation Trust Company. The registe |
|
| March 1, 2021 |
Exhibit 3.1 Page 1 Delaware The First State I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF INCORPORATION OF ?REVOLUTION HEALTHCARE ACQUISITION CORP. ?, FILED IN THIS OFFICE ON THE ELEVENTH DAY OF JANUARY, A. D. 2021, AT 4:41 O`CLOCK P.M. 4523147 8100 SR# 20210079742 Authentication: 202262509 Date: |
|
| March 1, 2021 |
Securities Subscription Agreement, dated January 11, 2021, between the Registrant and the Sponsor. Exhibit 10.7 Revolution Healthcare Acquisition Corp. 20 University Road Cambridge, MA 02138 January 11, 2021 REV Sponsor LLC 20 University Road Cambridge, MA 02138 RE: Securities Subscription Agreement Ladies and Gentlemen: This agreement (this ?Agreement?) is entered into on January 11, 2021 by and between REV Sponsor LLC, a Delaware limited liability company (the ?Subscriber ? or ?you?), and Rev |
|
| March 1, 2021 |
Form S-1 (File No. 333-253729) TABLE OF CONTENTS As filed with the Securities and Exchange Commission on March 1, 2021 No. |
|
| March 1, 2021 |
Exhibit 10.2 REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT (this ?Agreement?), dated as of February [], 2021, is made and entered into by and among Revolution Healthcare Acquisition Corp., a Delaware corporation (the ?Company?), REV Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), Health Assurance Economy Foundation, a Delaware n |
|
| March 1, 2021 |
Form of Administrative Services Agreement between the Registrant and the Sponsor. Exhibit 10.5 REVOLUTION HEALTHCARE ACQUISITION CORP. 20 University Road Cambridge, MA 02138 , 2021 REV Sponsor LLC 20 University Road Cambridge, MA 02138 Re: Administrative Support Agreement Ladies and Gentlemen: This letter agreement by and between Revolution Healthcare Acquisition Corp. (the ?Company?) and REV Sponsor LLC (?Sponsor?), dated as of the date hereof, will confirm our agreement that, |
|
| March 1, 2021 |
Form of Amended and Restated Certificate of Incorporation. Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF REVOLUTION HEALTHCARE ACQUISITION CORP. February , 2021 Revolution Healthcare Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is ?Revolution Healthcare Acquisition Corp.?. The original certificate of inc |
|
| March 1, 2021 |
Exhibit 4.1 NUMBER SAILSM securities U- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 76155Y108 REVOLUTION HEALTHCARE ACQUISITION CORP. SAILSM (STAKEHOLDER ALIGNED INITIAL LISTING) SECURITY CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE-FIFTH OF ONE WARRANT TO PURCHASE ONE SHARE OF CLASS A COMMON STOCK THIS CERTIFIES THAT is the owner of SAILSM securities. Each SAILSM security (?SAILSM securi |
|
| March 1, 2021 |
Specimen Class A Common Stock. Exhibit 4.2 NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 76155Y108 REVOLUTION HEALTHCARE ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CLASS A COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE CLASS A COMMON STOCK OF REVOLUTION HEALTHCARE ACQUISITION CORP. (THE ?CORPORATION?) transfer |
|
| February 1, 2021 |
DRS 1 filename1.htm TABLE OF CONTENTS As confidentially submitted to the Securities and Exchange Commission on February 1, 2021. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains confidential. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEME |
